Compare Quest Diagnostics Inc (DGX) vs Snowflake Inc (SNOW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Snowflake Inc — how do they compare? Quest Diagnostics Inc trades at $230.82 (market cap $25.48B), while Snowflake Inc trades at $357.95 (market cap $121.15B). The key difference: Snowflake Inc is far larger — about 4.8× Quest Diagnostics Inc's market cap, and Quest Diagnostics Inc pays a 1.49% dividend while Snowflake Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and Snowflake Inc for 54 Days on average.
| DGX | SNOW | |
|---|---|---|
Market Cap | $25.48B | $121.15B |
Volume | 941,866 | 3,986,549 |
Sector | Health | Technology |
52-Week High | $247.45 | $356.47 |
52-Week Low | $173.49 | $121.11 |
Typical Hold Time | 56 Days | 54 Days |
Enterprise Value | $31.23B | $121.57B |
Dividend Yield | 1.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $227.00, down 0.64% with a bearish technical signal. The company shows strong fundamentals with three consecutive quarterly earnings beats and revenue growth from $9.9B in 2024 to $11.0B in 2025. Recent developments include positive clinical study results and a new Apple Health integration, though Medicare reimbursement cuts pose headwinds. The stock trades near support at $226 with oversold RSI readings suggesting potential for near-term bounce.
DGX presents a mixed outlook with solid execution offset by regulatory risks. The 10% upside to consensus price target of $250 offers opportunity, but Medicare payment reductions and rising debt levels require monitoring. Recent earnings momentum and strategic partnerships support growth, making DGX suitable for investors comfortable with healthcare sector volatility.
Snowflake (SNOW) trades at $332.85, down 0.92% on the day, with technical indicators showing a neutral bias amid strong analyst support. The company demonstrates robust revenue growth, reaching $3.63 billion in 2025, but continues to post significant net losses (-$1.29 billion). Recent developments include a $3.75 billion convertible note offering and expanded partnerships, positioning the company for future growth in the AI data cloud market.
Snowflake presents a compelling growth story with strong revenue momentum and dominant market positioning, though profitability remains a key challenge. The stock offers 25% upside to the consensus price target of $418.03, supported by overwhelming analyst bullishness (81% buy ratings). However, investors face risks from ongoing losses, high valuation multiples, and competitive pressures in the cloud data sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Snowflake Inc
Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that came public in 2020. To date, the company has over 3,000 customers including nearly 30% of the Fortune 500 as its customers. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to easily buy and ingest data almost instantaneously compared with a traditionally months-long process. Overall, the company is known for the fact that all of its data solutions that can be hosted on various public clouds.
Read more on SNOW →
